InvestorsHub Logo
Followers 171
Posts 22597
Boards Moderated 0
Alias Born 11/01/2012

Re: None

Wednesday, 07/20/2022 11:59:00 AM

Wednesday, July 20, 2022 11:59:00 AM

Post# of 2099
Vascular Biogenics (VBLT) Receives a Hold from JonesTrading

Source: TipRanks
In a report released today, Soumit Roy from JonesTrading maintained a Hold rating on Vascular Biogenics (VBLT – Research Report). The company's shares closed last Tuesday at $2.05. According to TipRanks.com, Roy is a 4-star analyst with an average return of 5.5% and a 32.0% success rate. Roy covers the Healthcare sector, focusing on stocks such as Deciphera Pharmaceuticals, Actinium Pharmaceuticals, and Adaptimmune Therapeutics. Currently, the analyst consensus on Vascular Biogenics is a Hold with an average price target of $5.00, which is a 143.9% upside from current levels. In a report released today, Oppenheimer also downgraded the stock to Hold.
https://www.tipranks.com/news/blurbs/vascular-biogenics-vblt-receives-a-hold-from-jonestrading?utm_source=advfn.com&utm_medium=referral
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VBLT News